- Title
- Prenatal phthalate exposure in relation to placental corticotropin releasing hormone (pCRH) in the CANDLE cohort
- Creator
- Barrett, Emily S.; Corsetti, Matthew; Tylavsky, Frances A.; Bush, Nicole R.; Sathyanarayana, Sheela; Day, Drew; Thurston, Sally W.; Loftus, Christine T.; Karr, Catherine J.; Kannan, Kurunthachalam; LeWinn, Kaja Z.; Smith, Alicia K.; Smith, Roger
- Relation
- Environment International Vol. 160, Issue February 2020, no. 107078
- Publisher Link
- http://dx.doi.org/10.1016/j.envint.2022.107078
- Publisher
- Elsevier
- Resource Type
- journal article
- Date
- 2022
- Description
- CONTEXT: Phthalates may disrupt maternal-fetal-placental endocrine pathways, affecting pregnancy outcomes and child development. Placental corticotropin releasing hormone (pCRH) is critical for healthy pregnancy and child development, but understudied as a target of endocrine disruption. OBJECTIVE: To examine phthalate metabolite concentrations (as mixtures and individually) in relation to pCRH. DESIGN: Secondary data analysis from a prospective cohort study. SETTING: Prenatal clinics in Tennessee, USA. PATIENTS: 1018 pregnant women (61.4% non-Hispanic Black, 32% non-Hispanic White, 6.6% other) participated in the CANDLE study and provided data. Inclusion criteria included: low-medical-risk singleton pregnancy, age 16-40, and gestational weeks 16-29. INTERVENTION: None. MAIN OUTCOME MEASURES: Plasma pCRH at two visits (mean gestational ages 23.0 and 31.8 weeks) and change in pCRH between visits (ΔpCRH). RESULTS: In weighted quantile sums (WQS) regression models, phthalate mixtures were associated with higher pCRH at Visit 1 (β = 0.07, 95 %CI: 0.02, 0.11) but lower pCRH at Visit 2 (β = -0.08, 95 %CI: -0.14, -0.02). In stratified analyses, among women with gestational diabetes (n = 59), phthalate mixtures were associated with lower pCRH at Visit 1 (β = -0.17, 95 %CI: -0.35, 0.0006) and Visit 2 (β = -0.35, 95 %CI: -0.50, -0.19), as well as greater ΔpCRH (β = 0.16, 95 %CI: 0.07, 0.25). Among women with gestational hypertension (n = 102), phthalate mixtures were associated with higher pCRH at Visit 1 (β = 0.20, 95 %CI: 0.03, 0.36) and Visit 2 (β = 0.42; 95 %CI: 0.19, 0.64) and lower ΔpCRH (β = -0.17, 95 %CI: -0.29, -0.06). Significant interactions between individual phthalate metabolites and pregnancy complications were observed. CONCLUSIONS: Phthalates may impact placental CRH secretion, with differing effects across pregnancy. Differences in results between women with and without gestational diabetes and gestational hypertension suggest a need for further research examining whether women with pregnancy complications may be more vulnerable to endocrine-disrupting effects of phthalates.
- Subject
- Phthalates; disrupting chemicals; pregnancy complications; corticotropin releasing hormone; placenta; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1457805
- Identifier
- uon:45377
- Identifier
- ISSN:0160-4120
- Rights
- © 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
- Language
- eng
- Full Text
- Reviewed
- Hits: 3810
- Visitors: 3943
- Downloads: 146
Collections
Goal 3: Good Health and Well-Being
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT02 | Publisher version (open access) | 2 MB | Adobe Acrobat PDF | View Details Download |